Evidence map›Paper›PMID 25827531›Full record

ArticleVirology2015

Immune evasion activities of accessory proteins Vpu, Nef and Vif are conserved in acute and chronic HIV-1 infection.

Petra Mlcochova, Luis Apolonia, Silvia F Kluge, Aishwarya Sridharan, Frank Kirchhoff, Michael H Malim, Daniel Sauter, Ravindra K Gupta

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Petra MlcochovaDepartment of Infection, University College London, London, UK.
Luis ApoloniaDepartment of Infectious Diseases, King׳s College London, London, UK.
Silvia F KlugeInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Aishwarya SridharanDepartment of Infection, University College London, London, UK.
Frank KirchhoffInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Michael H MalimDepartment of Infectious Diseases, King׳s College London, London, UK.
Daniel SauterInstitute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
Ravindra K GuptaDepartment of Infection, University College London, London, UK.
Universität Ulm · DEUniversity College London · GBKing's College London · GB

Funding

Medical Research Council G1000196Medical Research Council G1001081Wellcome TrustWellcome Trust WT093722MA
6 · The paper itself

Abstract

Heterosexual HIV-1 transmission has been identified as a genetic bottleneck and a single transmitted/founder (T/F) variant with reduced sensitivity to type I interferon initiates productive infection in most cases. We hypothesized that particularly active accessory protein(s) may confer T/F viruses with a selective advantage in establishing HIV infection. Thus, we tested vpu, vif and nef alleles from six T/F and six chronic (CC) viruses in assays for 9 immune evasion activities involving the counteraction of interferon-stimulated genes and modulation of ligands known to activate innate immune cells. All functions were highly conserved with no significant differences between T/F and CC viruses, suggesting that these accessory protein functions are important throughout the course of infection.

Indexed as

Immune EvasionCell LineFemaleHIV-1HIV InfectionsHuman Immunodeficiency Virus ProteinsHumansMalenef Gene Products, Human Immunodeficiency Virusvif Gene Products, Human Immunodeficiency VirusViral Regulatory and Accessory ProteinsViroporin ProteinsVirus ReplicationHuman Immunodeficiency Virus Proteinsnef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1vif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1Viral Regulatory and Accessory ProteinsViroporin Proteinsvpu protein, Human immunodeficiency virus 1AccessoryAcuteChronicHIVNefVifVpu

Identifiers

PMID25827531
PMCPMC4503796
OpenAlexW1965792180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.